首页> 外文期刊>Clinical and experimental allergy : >Serine protease Per a 10 from Periplaneta americana bias dendritic cells towards type 2 by upregulating CD86 and low IL-12 secretions
【24h】

Serine protease Per a 10 from Periplaneta americana bias dendritic cells towards type 2 by upregulating CD86 and low IL-12 secretions

机译:Periplaneta americana的每10个丝氨酸蛋白酶通过上调CD86和低IL-12分泌使树突状细胞偏向2型

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Serine protease activity of Per a 10 from Periplaneta americana induces air-way inflammation and systemic Th2 response towards self and bystander allergen. Objective: In the present study the effect of proteolytic activity of Per a 10 allergen on dendritic cells (DCs) polarization and consequent T cell response was investigated. Methods: Non-atopic subjects with no family history of asthma/allergy were recruited for the study. CD14 + peripheral blood monocytes were purified, differentiated to immature DCs and stimulated with proteolytically active/inactivated native or recombinant Per a 10. DCs phenotype was analysed with flow cytometry and antigen presenting function assessed by co-culturing with autologous CD4 + T cells. Cytokine levels were determined using ELISA. Results: Immature DCs differentiated into mature CD14 -CD83 +HLA-DR + cells after incubating with proteolytically active/inactivated or recombinant Per a 10. Proteolytically active Per a 10 induced significant CD86 up-regulation on DCs compared to inactivated or recombinant Per a 10 lacking enzymatic activity. Proteolytic activity of Per a 10 showed dose-dependent effect on expression of CD80, CD86, CD83, CD1a and HLA-DR. However, no significant differences were observed phenotypically in active or inactive forms except for CD86. Active Per a 10 stimulated DCs secreted significantly low IL-12 (P 0.01) and high IL-6, compared to inactive forms of Per a 10. Naive CD4 + T cells primed with active Per a 10 pulsed DCs also secreted significantly less IL-12 (P 0.01) and high IL-4, IL-5 plus IL-6 (P 0.01); in contrast to DCs pulsed with inactivated or recombinant Per a 10. Conclusion and clinical relevance: Proteolytic activity of Per a 10 modulates DCs towards type 2 by CD86 up-regulation, high IL-6 and reduced IL-12 secretions. Proteolytically inactive Per a 10 can be further explored for immunotherapy.
机译:背景:来自美洲大plane的Per a 10的丝氨酸蛋白酶活性诱导气道炎症和对自身和旁观者过敏原的全身Th2反应。目的:在本研究中,研究了Per 10过敏原的蛋白水解活性对树突状细胞(DCs)极化和随之而来的T细胞反应的影响。方法:招募没有哮喘/过敏家族史的非过敏性受试者。纯化CD14 +外周血单核细胞,分化为未成熟的DC,并用蛋白水解活性/失活的天然或重组Per 10刺激。用流式细胞仪分析DC的表型,并通过与自体CD4 + T细胞共培养评估抗原呈递功能。使用ELISA确定细胞因子水平。结果:未成熟的DC与蛋白水解活性/失活或重组的Per 10孵育后,分化为成熟的CD14-CD83 + HLA-DR +细胞。与失活或重组的Per 10相比,蛋白水解活性的Per 10诱导DC的CD86明显上调。缺乏酶活性。 Per 10的蛋白水解活性对CD80,CD86,CD83,CD1a和HLA-DR的表达表现出剂量依赖性。但是,除了CD86外,在活性或非活性形式上没有观察到显着差异。与无活性形式的Per 10相比,每10个刺激的DC分泌的IL-12(P <0.01)和IL-6的活性显着降低,而每10个脉冲DC具有活性的天然CD4 + T细胞也分泌的IL少得多-12(P <0.01)和高IL-4,IL-5加IL-6(P <0.01);与用灭活的或重组的Per 10脉冲的DC形成对比。结论和临床意义:Per 10的蛋白水解活性通过CD86上调,高IL-6和减少的IL-12分泌来调节DC趋向2型。蛋白水解无活性的Per 10可以进一步用于免疫治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号